Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 224

1.

The status of sublingual immunotherapy in the treatment of allergic diseases.

Okubo K, Izuhara K.

Allergol Int. 2018 Jul;67(3):299-300. doi: 10.1016/j.alit.2018.06.001. No abstract available.

2.

Prospective predictors of exacerbation status in severe asthma over a 3-year follow-up.

Kimura H, Konno S, Makita H, Taniguchi N, Shimizu K, Suzuki M, Kimura H, Goudarzi H, Nakamaru Y, Ono J, Ohta S, Izuhara K, Ito YM, Wenzel SE, Nishimura M; Hi-CARAT investigators.

Clin Exp Allergy. 2018 May 21. doi: 10.1111/cea.13170. [Epub ahead of print]

PMID:
29781543
3.

IgE sensitization to food allergens and airborne allergens in relation to biomarkers of type 2 inflammation in asthma.

Patelis A, Alving K, Middelveld R, James A, Ono J, Ohta S, Izuhara K, Borres MP, Forsberg B, Janson C, Malinovschi A.

Clin Exp Allergy. 2018 May 10. doi: 10.1111/cea.13165. [Epub ahead of print]

PMID:
29746003
4.

Serum periostin levels serve as a biomarker for both eosinophilic airway inflammation and fixed airflow limitation in well-controlled asthmatics.

Takahashi K, Meguro K, Kawashima H, Kashiwakuma D, Kagami SI, Ohta S, Ono J, Izuhara K, Iwamoto I.

J Asthma. 2018 Apr 12:1-8. doi: 10.1080/02770903.2018.1455855. [Epub ahead of print]

PMID:
29648484
5.

Squamous Cell Carcinoma Antigen 2 (SCCA2, SERPINB4): An Emerging Biomarker for Skin Inflammatory Diseases.

Izuhara K, Yamaguchi Y, Ohta S, Nunomura S, Nanri Y, Azuma Y, Nomura N, Noguchi Y, Aihara M.

Int J Mol Sci. 2018 Apr 6;19(4). pii: E1102. doi: 10.3390/ijms19041102. Review.

6.

Asthma-chronic obstructive pulmonary disease overlap (ACO): An emerging entity in allergic respiratory diseases.

Tamaoki J, Izuhara K.

Allergol Int. 2018 Apr;67(2):163-164. doi: 10.1016/j.alit.2018.03.001. No abstract available.

7.

The IL-13/periostin/IL-24 pathway causes epidermal barrier dysfunction in allergic skin inflammation.

Mitamura Y, Nunomura S, Nanri Y, Ogawa M, Yoshihara T, Masuoka M, Tsuji G, Nakahara T, Hashimoto-Hachiya A, Conway SJ, Furue M, Izuhara K.

Allergy. 2018 Mar 12. doi: 10.1111/all.13437. [Epub ahead of print]

PMID:
29528494
8.

Periostin antisense oligonucleotide suppresses bleomycin-induced formation of a lung premetastatic niche for melanoma.

Semba T, Sugihara E, Kamoshita N, Ueno S, Fukuda K, Yoshino M, Takao K, Yoshikawa K, Izuhara K, Arima Y, Suzuki M, Saya H.

Cancer Sci. 2018 May;109(5):1447-1454. doi: 10.1111/cas.13554. Epub 2018 Mar 31.

9.

Pro-fibrotic phenotype of human skin fibroblasts induced by periostin via modulating TGF-β signaling.

Kanaoka M, Yamaguchi Y, Komitsu N, Feghali-Bostwick CA, Ogawa M, Arima K, Izuhara K, Aihara M.

J Dermatol Sci. 2018 May;90(2):199-208. doi: 10.1016/j.jdermsci.2018.02.001. Epub 2018 Feb 6.

PMID:
29433908
10.

SCCA2 is a reliable biomarker for evaluating pediatric atopic dermatitis.

Nagao M, Inagaki S, Kawano T, Azuma Y, Nomura N, Noguchi Y, Ohta S, Kawaguchi A, Odajima H, Ohya Y, Fujisawa T, Izuhara K.

J Allergy Clin Immunol. 2018 May;141(5):1934-1936.e11. doi: 10.1016/j.jaci.2018.01.021. Epub 2018 Feb 5. No abstract available.

PMID:
29421276
11.

Constitutive overexpression of periostin delays wound healing in mouse skin.

Nunomura S, Nanri Y, Ogawa M, Arima K, Mitamura Y, Yoshihara T, Hasuwa H, Conway SJ, Izuhara K.

Wound Repair Regen. 2018 Jan;26(1):6-15. doi: 10.1111/wrr.12616. Epub 2018 Mar 7.

PMID:
29418037
12.

Periostin promotes malignant potential by induction of epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma.

Mino M, Kanno K, Okimoto K, Sugiyama A, Kishikawa N, Kobayashi T, Ono J, Izuhara K, Kobayashi T, Ohigashi T, Ohdan H, Tazuma S.

Hepatol Commun. 2017 Oct 25;1(10):1099-1109. doi: 10.1002/hep4.1114. eCollection 2017 Dec.

13.

The Significance of Hypothiocyanite Production via the Pendrin/DUOX/Peroxidase Pathway in the Pathogenesis of Asthma.

Izuhara K, Suzuki S, Ogawa M, Nunomura S, Nanri Y, Mitamura Y, Yoshihara T.

Oxid Med Cell Longev. 2017;2017:1054801. doi: 10.1155/2017/1054801. Epub 2017 Nov 22. Review.

14.

Barrier dysfunction in allergy.

Kabashima K, Izuhara K.

Allergol Int. 2018 Jan;67(1):1-2. doi: 10.1016/j.alit.2017.12.001. No abstract available.

15.

Serum periostin is associated with body mass index and allergic rhinitis in healthy and asthmatic subjects.

Kimura H, Konno S, Makita H, Taniguchi N, Kimura H, Goudarzi H, Shimizu K, Suzuki M, Shijubo N, Shigehara K, Ono J, Izuhara K, Ito YM, Nishimura M.

Allergol Int. 2018 Jul;67(3):357-363. doi: 10.1016/j.alit.2017.11.006. Epub 2017 Dec 7.

16.

Periostin Expression in Non-Small Cell Lung Cancer: Clinical Significance.

Murakami D, Takamori S, Kawahara A, Mitsuoka M, Kashihara M, Yoshiyama K, Matsumoto R, Yokoyama S, Fujimoto K, Kawaguchi A, Izuhara K, Akagi Y.

Kurume Med J. 2018 Feb 26;64(1.2):13-20. doi: 10.2739/kurumemedj.MS640012. Epub 2017 Nov 27.

17.

Up-regulation of serum periostin and squamous cell carcinoma antigen levels in infants with acute bronchitis due to respiratory syncytial virus.

Nakamura H, Akashi K, Watanabe M, Ohta S, Ono J, Azuma Y, Ogasawara N, Yamamoto K, Shimizu N, Tsutsumi H, Izuhara K, Katsunuma T.

Allergol Int. 2018 Apr;67(2):259-265. doi: 10.1016/j.alit.2017.10.003. Epub 2017 Nov 6.

18.

Monitoring inflammatory heterogeneity with multiple biomarkers for multidimensional endotyping of asthma.

Agache I, Strasser DS, Pierlot GM, Farine H, Izuhara K, Akdis CA.

J Allergy Clin Immunol. 2018 Jan;141(1):442-445. doi: 10.1016/j.jaci.2017.08.027. Epub 2017 Oct 5. No abstract available.

PMID:
28987809
19.

Old friends, microbes, and allergic diseases.

Shimojo N, Izuhara K.

Allergol Int. 2017 Oct;66(4):513-514. doi: 10.1016/j.alit.2017.08.009. No abstract available.

20.

Serum Biomarkers for the Diagnosis of Eosinophilic Esophagitis and Eosinophilic Gastroenteritis.

Ishihara S, Shoda T, Ishimura N, Ohta S, Ono J, Azuma Y, Okimoto E, Izuhara K, Nomura I, Matsumoto K, Kinoshita Y.

Intern Med. 2017 Nov 1;56(21):2819-2825. doi: 10.2169/internalmedicine.8763-16. Epub 2017 Sep 25.

21.

Erratum to: Allergen immunotherapy for allergic asthma: protocol for a systematic review.

Dhami S, Nurmatov U, Agache I, Lau S, Muraro A, Jutel M, Roberts G, Akdis C, Bonini M, Calderon M, Casale T, Cavkaytar O, Cox L, Demoly P, Flood B, Hamelmann E, Izuhara K, Kalayci Ö, Kleine-Tebbe J, Nieto A, Papadopoulos N, Pfaar O, Rosenwasser L, Ryan D, Schmidt-Weber C, Szefler S, Wahn U, van Wijk RG, Wilkinson J, Sheikh A.

Clin Transl Allergy. 2017 Sep 15;7:32. doi: 10.1186/s13601-017-0167-6. eCollection 2017.

22.

Periostin in inflammation and allergy.

Izuhara K, Nunomura S, Nanri Y, Ogawa M, Ono J, Mitamura Y, Yoshihara T.

Cell Mol Life Sci. 2017 Dec;74(23):4293-4303. doi: 10.1007/s00018-017-2648-0. Epub 2017 Sep 8. Review.

PMID:
28887633
23.

Subphenotypes of type 2 severe asthma in adults.

Matsusaka M, Fukunaga K, Kabata H, Izuhara K, Asano K, Betsuyaku T.

J Allergy Clin Immunol Pract. 2018 Jan - Feb;6(1):274-276.e2. doi: 10.1016/j.jaip.2017.06.015. Epub 2017 Aug 9. No abstract available.

PMID:
28803182
24.

Characteristics of severe asthma with fungal sensitization.

Masaki K, Fukunaga K, Matsusaka M, Kabata H, Tanosaki T, Mochimaru T, Kamatani T, Ohtsuka K, Baba R, Ueda S, Suzuki Y, Sakamaki F, Oyamada Y, Inoue T, Oguma T, Sayama K, Koh H, Nakamura M, Umeda A, Kamei K, Izuhara K, Asano K, Betsuyaku T.

Ann Allergy Asthma Immunol. 2017 Sep;119(3):253-257. doi: 10.1016/j.anai.2017.07.008. Epub 2017 Aug 8.

PMID:
28801088
25.

Allergen immunotherapy for allergic asthma: a systematic overview of systematic reviews.

Asamoah F, Kakourou A, Dhami S, Lau S, Agache I, Muraro A, Roberts G, Akdis C, Bonini M, Cavkaytar O, Flood B, Izuhara K, Jutel M, Kalayci Ö, Pfaar O, Sheikh A.

Clin Transl Allergy. 2017 Aug 2;7:25. doi: 10.1186/s13601-017-0160-0. eCollection 2017. Review.

26.

Serum levels of squamous cell carcinoma antigens 1 and 2 reflect disease severity and clinical type of atopic dermatitis in adult patients.

Okawa T, Yamaguchi Y, Kou K, Ono J, Azuma Y, Komitsu N, Inoue Y, Kohno M, Matsukura S, Kambara T, Ohta S, Izuhara K, Aihara M.

Allergol Int. 2018 Jan;67(1):124-130. doi: 10.1016/j.alit.2017.06.016. Epub 2017 Jul 19.

27.

PERIOSTIN IN ALLERGIC DISEASES.

Izuhara K.

Arerugi. 2017;66(6):792-797. doi: 10.15036/arerugi.66.792. Review. Japanese. No abstract available.

PMID:
28701644
28.

Clustering of patients with intrahepatic cholangiocarcinoma based on serum periostin may be predictive of prognosis.

Thuwajit C, Thuwajit P, Jamjantra P, Pairojkul C, Wongkham S, Bhudhisawasdi V, Ono J, Ohta S, Fujimoto K, Izuhara K.

Oncol Lett. 2017 Jul;14(1):623-634. doi: 10.3892/ol.2017.6250. Epub 2017 May 25.

29.

Beyond Th2, more than ILC2.

Izuhara K.

Allergol Int. 2017 Jul;66(3):367-368. doi: 10.1016/j.alit.2017.06.007. No abstract available.

30.

Allergen immunotherapy for allergic asthma: A systematic review and meta-analysis.

Dhami S, Kakourou A, Asamoah F, Agache I, Lau S, Jutel M, Muraro A, Roberts G, Akdis CA, Bonini M, Cavkaytar O, Flood B, Gajdanowicz P, Izuhara K, Kalayci Ö, Mosges R, Palomares O, Pfaar O, Smolinska S, Sokolowska M, Asaria M, Netuveli G, Zaman H, Akhlaq A, Sheikh A.

Allergy. 2017 Dec;72(12):1825-1848. doi: 10.1111/all.13208. Epub 2017 Jul 6. Review.

PMID:
28543086
31.

Serum periostin relates to type-2 inflammation and lung function in asthma: Data from the large population-based cohort Swedish GA(2)LEN.

James A, Janson C, Malinovschi A, Holweg C, Alving K, Ono J, Ohta S, Ek A, Middelveld R, Dahlén B, Forsberg B, Izuhara K, Dahlén SE.

Allergy. 2017 Nov;72(11):1753-1760. doi: 10.1111/all.13181. Epub 2017 May 22.

PMID:
28398635
32.

Japanese guidelines for allergic diseases 2017.

Ohta K, Izuhara K.

Allergol Int. 2017 Apr;66(2):161-162. doi: 10.1016/j.alit.2017.03.003. No abstract available.

33.

The usefulness of monomeric periostin as a biomarker for idiopathic pulmonary fibrosis.

Ohta S, Okamoto M, Fujimoto K, Sakamoto N, Takahashi K, Yamamoto H, Kushima H, Ishii H, Akasaka K, Ono J, Kamei A, Azuma Y, Matsumoto H, Yamaguchi Y, Aihara M, Johkoh T, Kawaguchi A, Ichiki M, Sagara H, Kadota JI, Hanaoka M, Hayashi SI, Kohno S, Hoshino T, Izuhara K; Consortium for Development of Diagnostics for Pulmonary Fibrosis Patients (CoDD-PF).

PLoS One. 2017 Mar 29;12(3):e0174547. doi: 10.1371/journal.pone.0174547. eCollection 2017.

34.

IL4Rα and ADAM33 as genetic markers in asthma exacerbations and type-2 inflammatory endotype.

Sunadome H, Matsumoto H, Petrova G, Kanemitsu Y, Tohda Y, Horiguchi T, Kita H, Kuwabara K, Tomii K, Otsuka K, Fujimura M, Ohkura N, Tomita K, Yokoyama A, Ohnishi H, Nakano Y, Oguma T, Hozawa S, Nagasaki T, Ito I, Oguma T, Inoue H, Tajiri T, Iwata T, Izuhara Y, Ono J, Ohta S, Hirota T, Tamari M, Yokoyama T, Niimi A, Izuhara K, Mishima M.

Clin Exp Allergy. 2017 Aug;47(8):998-1006. doi: 10.1111/cea.12927. Epub 2017 Apr 21.

PMID:
28326636
35.

Therapeutic Effect of Novel Single-Stranded RNAi Agent Targeting Periostin in Eyes with Retinal Neovascularization.

Nakama T, Yoshida S, Ishikawa K, Kubo Y, Kobayashi Y, Zhou Y, Nakao S, Hisatomi T, Ikeda Y, Takao K, Yoshikawa K, Matsuda A, Ono J, Ohta S, Izuhara K, Kudo A, Sonoda KH, Ishibashi T.

Mol Ther Nucleic Acids. 2017 Mar 17;6:279-289. doi: 10.1016/j.omtn.2017.01.004. Epub 2017 Feb 9.

36.

Utility of serum periostin in combination with exhaled nitric oxide in the management of asthma.

Nagasaki T, Matsumoto H, Izuhara K; KiHAC Respiratory Medicine Group.

Allergol Int. 2017 Jul;66(3):404-410. doi: 10.1016/j.alit.2017.02.003. Epub 2017 Feb 28. Review.

37.

Serum Periostin as a Biomarker for Comorbid Chronic Rhinosinusitis in Patients with Asthma.

Asano T, Kanemitsu Y, Takemura M, Yokota M, Fukumitsu K, Takeda N, Ichikawa H, Uemura T, Takakuwa O, Ohkubo H, Maeno K, Ito Y, Oguri T, Maki Y, Ono J, Ohta S, Nakamura Y, Izuhara K, Suzuki M, Niimi A.

Ann Am Thorac Soc. 2017 May;14(5):667-675. doi: 10.1513/AnnalsATS.201609-720OC.

PMID:
28248547
38.

Clarithromycin attenuates IL-13-induced periostin production in human lung fibroblasts.

Komiya K, Ohta S, Arima K, Ogawa M, Suzuki S, Mitamura Y, Nunomura S, Nanri Y, Yoshihara T, Kawaguchi A, Kadota JI, Rubin BK, Izuhara K.

Respir Res. 2017 Feb 20;18(1):37. doi: 10.1186/s12931-017-0519-8.

39.

Itch: Its perception and involvement in allergy.

Katayama I, Izuhara K.

Allergol Int. 2017 Jan;66(1):1-2. doi: 10.1016/j.alit.2016.11.004. No abstract available.

40.

Staphylococcus aureus enterotoxin sensitization involvement and its association with the CysLTR1 variant in different asthma phenotypes.

Matsumoto H, Kanemitsu Y, Nagasaki T, Tohda Y, Horiguchi T, Kita H, Kuwabara K, Tomii K, Otsuka K, Fujimura M, Ohkura N, Tomita K, Yokoyama A, Ohnishi H, Nakano Y, Oguma T, Hozawa S, Izuhara Y, Ito I, Oguma T, Inoue H, Tajiri T, Iwata T, Ono J, Ohta S, Hirota T, Kawaguchi T, Tamari M, Yokoyama T, Tabara Y, Matsuda F, Izuhara K, Niimi A, Mishima M.

Ann Allergy Asthma Immunol. 2017 Feb;118(2):197-203. doi: 10.1016/j.anai.2016.11.013. Epub 2016 Dec 27.

PMID:
28034578
41.

Sinus Computed Tomographic Findings in Adult Smokers and Nonsmokers with Asthma. Analysis of Clinical Indices and Biomarkers.

Kimura H, Konno S, Nakamaru Y, Makita H, Taniguchi N, Shimizu K, Suzuki M, Ono J, Ohta S, Izuhara K, Nishimura M; Hokkaido-based Investigative Cohort Analysis for Refractory Asthma Investigators.

Ann Am Thorac Soc. 2017 Mar;14(3):332-341. doi: 10.1513/AnnalsATS.201606-463OC.

PMID:
28029801
42.

Induction of Airway Allergic Inflammation by Hypothiocyanite via Epithelial Cells.

Suzuki S, Ogawa M, Ohta S, Nunomura S, Nanri Y, Shiraishi H, Mitamura Y, Yoshihara T, Lee JJ, Izuhara K.

J Biol Chem. 2016 Dec 30;291(53):27219-27227. doi: 10.1074/jbc.M116.746909. Epub 2016 Nov 18.

43.

Food allergy: Current perspectives.

Ebisawa M, Izuhara K.

Allergol Int. 2016 Oct;65(4):361-362. doi: 10.1016/j.alit.2016.08.012. No abstract available.

44.

Using Periostin as a Biomarker in the Treatment of Asthma.

Izuhara K, Ohta S, Ono J.

Allergy Asthma Immunol Res. 2016 Nov;8(6):491-8. doi: 10.4168/aair.2016.8.6.491. Review.

45.

Circulating activated innate lymphoid cells and mucosal-associated invariant T cells are associated with airflow limitation in patients with asthma.

Ishimori A, Harada N, Chiba A, Harada S, Matsuno K, Makino F, Ito J, Ohta S, Ono J, Atsuta R, Izuhara K, Takahashi K, Miyake S.

Allergol Int. 2017 Apr;66(2):302-309. doi: 10.1016/j.alit.2016.07.005. Epub 2016 Aug 27.

46.

Inhibition of IL-13-induced periostin in airway epithelium attenuates cellular protein expression of MUC5AC.

Suzaki I, Kawano S, Komiya K, Tanabe T, Akaba T, Asano K, Suzaki H, Izuhara K, Rubin BK.

Respirology. 2017 Jan;22(1):93-100. doi: 10.1111/resp.12873. Epub 2016 Aug 24.

PMID:
27553766
47.

The potential for repositioning antithyroid agents as antiasthma drugs.

Suzuki S, Ogawa M, Ohta S, Arima K, Nunomura S, Nanri Y, Mitamura Y, Yoshihara T, Nakamura Y, Yamauchi K, Chibana K, Ishii Y, Lee JJ, Aratani Y, Kakuta S, Kubo S, Iwakura Y, Yoshida H, Izuhara K.

J Allergy Clin Immunol. 2016 Nov;138(5):1458-1461.e8. doi: 10.1016/j.jaci.2016.04.047. Epub 2016 Jun 15. No abstract available.

PMID:
27444178
48.

Development of in vivo imaging.

Kabashima K, Izuhara K.

Allergol Int. 2016 Jul;65(3):223-4. doi: 10.1016/j.alit.2016.06.002. No abstract available.

49.

Periostin and Interleukin-13 Are Independently Related to Chronic Spontaneous Urticaria.

Bae Y, Izuhara K, Ohta S, Ono J, Hong GU, Ro JY, Park GH, Choi JH.

Allergy Asthma Immunol Res. 2016 Sep;8(5):457-60. doi: 10.4168/aair.2016.8.5.457.

50.

Clinical implication of the serum periostin level for differentiating phenotypes of NSAID hypersensitivity.

Kim MA, Yoon MK, Lee YS, Izuhara K, Ohta S, Ono J, Kim JH, Ban GY, Ye YM, Park HS.

Allergol Int. 2016 Oct;65(4):492-494. doi: 10.1016/j.alit.2016.04.013. Epub 2016 May 25. No abstract available.

Supplemental Content

Loading ...
Support Center